Anti-KIR3DL2/CD158k Antibody (Lacutamab)
Catalog No.
F1613
Anti-KIR3DL2/CD158k Antibody (Lacutamab)
Featured Products
Lacutamab (IPH4102) is a novel anti-inflammatory drug targeting immune receptor molecules.KIR3DL2 Lacutamab is a humanized monoclonal antibody (mAb) produced in CHO cells by recombinant technology. Lacutamab can be used for the study of cutaneous T-cell lymphoma.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.52 kDa
Dry ice
2187368-16-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IPH4102, IPH 4101, IPH41
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P43630
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
KIR3DL2 / CD158k
Please avoid freeze-thaw cycles.